Zoetis ZTS
NYSE ZTS
$84.39 +0.57 (+0.68%)
At close: Nov 16, 2026 · 4:00 PM EST

Zoetis (ZTS) EBITDA Margin (2012 - 2026)

Updated

Zoetis' EBITDA Margin was 42.37% in Q3 2026, down 2.47 percentage points from 44.84% a year earlier and down 1.07 percentage points from the prior quarter.

Analysis

Zoetis (ZTS) EBITDA Margin (2012 - 2026) Analysis & Trends

For FY2025, EBITDA Margin at Zoetis came in at 43.95%, up 0.99 percentage points from FY2024.

  • EBITDA Margin shows a five-year change of +1.33 percentage points (FY2020 to FY2025).
  • In earlier years, EBITDA Margin was 42.97% in FY2024 (+0.18 pp), 42.79% in FY2023 (-0.92 pp), 43.71% in FY2022 (+0.39 pp) and 43.33% in FY2021 (+0.70 pp).
  • Quarterly EBITDA Margin has moved between 38.08% (Q4 2021) and 47.43% (Q1 2022) over five years.
  • Compared with a year earlier, EBITDA Margin has declined for three straight quarters, with an average year-over-year change of -0.22 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBITDA Margin over five years was Q4 2022 (a gain of 3.20 percentage points); the worst was Q1 2023 (a drop of 4.23 percentage points).
  • Per Business Quant data, ZTS's EBITDA Margin in the three quarters before Q3 2026 was 43.44% (Q2 2026), 42.00% (Q1 2026) and 41.64% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 32.68%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 46.88%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 40.60%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 39.77%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 46.62%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 50.63%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 42.49%
10 Zoetis 34.65 Bn 27.05 Bn 1.69 Bn 42.37%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 42.37%
Jun 30, 2026 43.44%
Mar 31, 2026 42.00%
Dec 31, 2025 41.64%
Sep 30, 2025 44.84%
Jun 30, 2025 45.43%
Mar 31, 2025 43.81%
Dec 31, 2024 39.71%
Sep 30, 2024 44.85%
Jun 30, 2024 43.46%
Mar 31, 2024 43.84%
Dec 31, 2023 39.04%
Sep 30, 2023 43.89%
Jun 30, 2023 45.14%
Mar 31, 2023 43.20%
Dec 31, 2022 41.27%
Sep 30, 2022 43.41%
Jun 30, 2022 42.84%
Mar 31, 2022 47.43%
Dec 31, 2021 38.08%
API Access

Zoetis EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZTS&period=max&api_key=YOUR_API_KEY